Your browser doesn't support javascript.
loading
Prevalence of evidence of inconsistency and its association with network structural characteristics in 201 published networks of interventions.
Veroniki, Areti Angeliki; Tsokani, Sofia; White, Ian R; Schwarzer, Guido; Rücker, Gerta; Mavridis, Dimitris; Higgins, Julian P T; Salanti, Georgia.
  • Veroniki AA; Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, 209 Victoria Street, Toronto, Ontario, M5B 1W8, Canada. areti-angeliki.veroniki@unityhealth.to.
  • Tsokani S; Institute of Reproductive and Developmental Biology, Department of Surgery & Cancer, Faculty of Medicine, Imperial College, London, UK. areti-angeliki.veroniki@unityhealth.to.
  • White IR; Department of Primary Education, School of Education University of Ioannina, Ioannina, Greece.
  • Schwarzer G; Medical Research Council Clinical Trials Unit (MRC CTU), Institute of Clinical Trials and Methodology, University College London, 90 High Holborn 2nd Floor, London, WC1V 6LJ, UK.
  • Rücker G; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Stefan-Meier-Strasse 26, 79104, Freiburg, Germany.
  • Mavridis D; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Stefan-Meier-Strasse 26, 79104, Freiburg, Germany.
  • Higgins JPT; Department of Primary Education, School of Education University of Ioannina, Ioannina, Greece.
  • Salanti G; Paris Descartes University, Sorbonne Paris Cité, Faculté de Médecine, Paris, France.
BMC Med Res Methodol ; 21(1): 224, 2021 10 25.
Article en En | MEDLINE | ID: mdl-34689743
ABSTRACT

BACKGROUND:

Network meta-analysis (NMA) has attracted growing interest in evidence-based medicine. Consistency between different sources of evidence is fundamental to the reliability of the NMA results. The purpose of the present study was to estimate the prevalence of evidence of inconsistency and describe its association with different NMA characteristics.

METHODS:

We updated our collection of NMAs with articles published up to July 2018. We included networks with randomised clinical trials, at least four treatment nodes, at least one closed loop, a dichotomous primary outcome, and available arm-level data. We assessed consistency using the design-by-treatment interaction (DBT) model and testing all the inconsistency parameters globally through the Wald-type chi-squared test statistic. We estimated the prevalence of evidence of inconsistency and its association with different network characteristics (e.g., number of studies, interventions, intervention comparisons, loops). We evaluated the influence of the network characteristics on the DBT p-value via a multivariable regression analysis and the estimated Pearson correlation coefficients. We also evaluated heterogeneity in NMA (consistency) and DBT (inconsistency) random-effects models.

RESULTS:

We included 201 published NMAs. The p-value of the design-by-treatment interaction (DBT) model was lower than 0.05 in 14% of the networks and lower than 0.10 in 20% of the networks. Networks including many studies and comparing few interventions were more likely to have small DBT p-values (less than 0.10), which is probably because they yielded more precise estimates and power to detect differences between designs was higher. In the presence of inconsistency (DBT p-value lower than 0.10), the consistency model displayed higher heterogeneity than the DBT model.

CONCLUSIONS:

Our findings show that inconsistency was more frequent than what would be expected by chance, suggesting that researchers should devote more resources to exploring how to mitigate inconsistency. The results of this study highlight the need to develop strategies to detect inconsistency (because of the relatively high prevalence of evidence of inconsistency in published networks), and particularly in cases where the existing tests have low power.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Reproducibilidad de los Resultados Tipo de estudio: Clinical_trials / Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Reproducibilidad de los Resultados Tipo de estudio: Clinical_trials / Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article